Editor's key points † A fibreoptic sensor was developed which can measure PO 2 continuously in blood. † The sensor was tested in animal models over a range of Pa O 2 values. † The sensor agreed with conventional blood gas analysis. † In a model of cyclical atelectasis, the sensor detected arterial PO 2 oscillations. † The sensor has clinical potential.
It is commonly accepted that arterial oxygenation remains essentially constant during the respiratory cycle in the healthy lung. Only minimal variations have been observed, with a period corresponding to the breathing period. 1 -4 In contrast, in some conditions of lung injury, the arterial partial pressure of oxygen (Pa O 2 ) is known to oscillate to a great extent. 5 -7 It is thought that these Pa O 2 oscillations are caused by alveolar opening during inspiration, when Pa O 2 increases, and by alveolar collapse during expiration, when Pa O 2 decreases; this phenomenon is called cyclical atelectasis (CA). This understanding is supported in part by evidence from imaging studies using, for example, computed tomography and positron emission tomography scans (reviewed in 8 and 9 ) and in part by studies using optical intravascular sensors, which showed Pa O 2 oscillations in animal models of lung injury. 6 7 10 -13 These insightful investigations have furthered our understanding of the relationship between Pa O 2 levels and lung mechanics, and have better informed the management of mechanical ventilation. However, investigations using fast Pa O 2 sensors have not yet been conducted in human patients because early embodiments of these sensors contained ruthenium, a toxic material, 14 which needs to be exposed in order for the sensors to achieve a sufficiently rapid response time. 15 The assessment of individual sensors is a critical step when using these prototype sensors for physiological or medical research. 15 -17 Furthermore, the relevance of animal studies and their translation into medical practice remain unclear, due, for example, to anatomical and pathophysiological differences between species. In order to avoid the requirement for a toxic component in these sensors, we produced a Pa O 2 sensor based on a platinum complex, immobilized in a polymer matrix, 18 19 which has the potential to be safely used in humans, once its reliability is established in large animal models. We recently showed that this sensor can detect up to 60 PO 2 oscillations per minute in vitro, simulating the occurrence of CA at a high respiratory rate. 17 We also showed that, when exposed to non-heparinized blood, the sensor is resistant to blood clotting at least for a period of 24 h in vivo.
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This sensor has the potential to become a useful diagnostic tool for CA in the acute respiratory distress syndrome (ARDS), or in other clinical scenarios where Pa O 2 is thought to change rapidly. Moreover, the continuous real-time Pa O 2 signal would provide immediate feedback on the effect of changes in ventilatory settings, which could be tailored on an individual basis, possibly leading towards a more personalized form of ventilation therapy.
This study aimed at establishing the sensor's response time, exploring the Pa O 2 range over which the sensor can generate reliable results, using standard blood gas analysis as a control measurement, and assessing whether it could detect Pa O 2 oscillations in an ovine model of ARDS in vivo.
Methods
The methods for the assessment of sensor's response time in vitro are presented elsewhere, 18 20 and outlined in the Supplementary material. All the animal experiments conformed to the National Institutes of Health Guidelines for the Use of Laboratory Animals. The protocols for the linearity experiments at the Charles University, Czech Republic, were approved by the local University Animal Care Committee. The protocols for the ovine lavage model studies were approved by the UK Home Office. At the end of each study, the animals were killed under anaesthesia with an overdose of pentobarbital ( 100 mg kg 21 ). Relevant sections of the ARRIVE guidelines were adhered to. In a second set of experiments, the linearity of the sensor was assessed at the University of Bristol, School of Veterinary Sciences, where a series of FI O 2 changes (similar to those presented above) were applied before induction of lung injury in three ovine models. Female sheep [weight 69 (2) kg; age 18 months] were obtained from a local commercial farm source. For these studies, the sensor was calibrated in vivo, on the basis of standard ABG analysis at baseline (i.e. FI O 2 ¼21%), and at FI O 2 of 35%; this range of values was chosen because it was associated with Pa O 2 values of about 11-20 kPa, where ABG analysis is frequently used. One PMMA sensor was used in each in vivo study (i.e. one for the porcine model, and three for the ovine models, such that a total of four sensors was used).
Assessment of sensor linearity

Detection of within-breath oscillations
To determine whether the sensor was capable of detecting within-breath Pa O 2 oscillations, one sheep with lavage-induced lung injury was studied at the School of Veterinary Sciences, University of Bristol, UK. An 18 G catheter was placed in the right cephalic vein and anaesthesia was induced with i.v. midazolam (0.4 mg kg 21 ) and propofol to effect ( 2 mg kg 21 ).
The trachea was intubated and anaesthesia maintained with isoflurane ( 1% end-tidal) with the Anaconda system (Sedana Medical AB, Stockholm, Sweden 
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Discussion
This study presents the first in vivo applications of a novel, fast intravascular Pa O 2 sensor, showing its capacity to track Pa O 2 changes over a wide range, covering physiological and pathophysiological Pa O 2 levels, and to detect Pa O 2 oscillations associated with the respiratory period at Pa O 2 levels close to 9 kPa.
These prototype sensors are not produced in series, hence differences in performance may vary considerably between sensors. 15 16 In order to avoid uncertainty in the interpretation of physiological results, it is essential that these sensors are tested individually, and that their performance is clearly defined before they are used for physiological studies. This rationale motivated our in vitro tests, where our sensor's response time was sufficiently fast to track the Pa Fast arterial oxygen sensing in vivo BJA that are expected to occur in animal models of lung injury. One limitation of this part of the study was in the testing of the response time of the sensor in the gas phase, while the in vivo measurements were performed in the liquid phase (i.e. in whole non-heparinized blood). From a technical perspective, the sensor's response time is independent of the medium that it samples, as it is only a function of oxygen diffusion and solubility within the sensor's matrix. Moreover, we have shown in heparinized whole blood that these sensors are capable of tracking up to 60 Pa O 2 oscillations per minute; 17 hence, even a relatively slow sensor would be able to follow the oscillations in our in vivo study (i.e. about 5 min
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). The results of these tests in gas (Supplementary Fig. 1 ) are presented here for future reference, since it will be easier and cheaper to test other prototype sensors in gas rather than the liquid phase.
The sensor's output is temperature-dependent, so calibration needs to be performed at the temperature at which the sensor will operate. In this study, our sensors were calibrated either a posteriori or in vivo, when the temperature was known and stable. These forms of calibrations are standard approaches, 22 26 27 although we acknowledge that further work must be done in order to make these sensors more easily usable for clinical settings, where 'plug-and-play' devices are more welcome. In general, a two point calibration is only practically useful if the sensor's signal is linear between these two points. The sensor had a very linear response to Pa O 2 changes, ranging from clinically relevant, low Pa O 2 levels, to rather elevated levels of around 70 kPa; this feature is a technical improvement over currently used optical sensors, which are normally designed to monitor either high or low PO 2 levels. In particular, our sensors were in strong agreement with results from standard blood gas analysis for the lower part of the Pa O 2 range studied, which is the range that is physiologically and clinically most interesting. As oxygen quenches the fluorescence intensity, the PMMA sensor's signal is intrinsically reduced at high PO 2 levels, a technical factor that may have increased the variability of the results and reduced the degree of agreement with standard ABG for Pa O 2 values .40 kPa. Apart from their accuracy, one of the greatest advantages of these fast sensors is their capacity to record Pa O 2 continuously, giving the opportunity to study dynamic Pa O 2 changes. The preliminary test of the sensor in vivo in a large animal model showed that the sensor accurately and rapidly responded to FI O 2 changes, as confirmed by standard ABG analysis. In response to a rapid change in FI O 2 , the Pa O 2 response appeared to be bi-phasic, characterized by an initial rapid phase, followed by a slower one. Although we can only speculate on the implications of this result, it seems possible that ultrafast Pa sensors could provide useful information for respiratory physiology and pathophysiology, in particular with reference to ventilatory distribution and oxygen uptake efficiency even in the absence of atelectasis/recruitment. Fast response time sensors afford the possibility to detect rapid Pa O 2 oscillations within breath in real time, like the oscillations that occur in CA. 6 7 In this respect, the novelty of our work does not lay at the proof-of-concept level, but rather in its potential to confirm this phenomenon in humans. Most importantly, to the best of our knowledge, this study is the first to show Pa O 2 oscillations in a clinically relevant range; previous studies investigated Pa O 2 levels that are much greater than those observed in a clinical scenario. 6 11 22 26 27 An alternative approach to assess the degree of variable shunt associated with CA involves standard ABG analysis, where arterial blood is sampled close to the end-inspiratory and end-expiratory stages, 13 a procedure that is rather cumbersome and, in our experience, unreliable. The within-breath variation in Pa O 2 levels is thought to be associated with CA, where gas exchange between alveoli and pulmonary circulation is impaired during the expiratory phase of the respiratory cycle, when alveolar collapse occurs. 6 7 This conclusion is also supported by dynamic computed tomography, positron emission tomography, and electric impedance tomography studies, showing less or more dense lung regions, presumably indicating aerated or collapsed lung. 28 -31 As in many previous studies of Pa O 2 oscillations in models of CA, one of the limitations of our study was in the lack of direct evidence of lung collapse, which was assumed on the basis of intermittently low Pa O 2 values. The nature of the relationship between the magnitude of Pa O 2 oscillations and CA is complex. It is generally accepted that an increase in the magnitude of Pa O 2 oscillations is associated with greater recruitment and derecruitment in CA. However, these phenomena must be looked at also in consideration of the mean Pa O 2 ; advanced mathematical modelling characterizing associations and relationships between these variables will contribute to a more accurate clinical interpretation of the oscillations. Studies exploring Pa O 2 oscillations at high mean Pa O 2 levels have the advantage of showing very clear oscillations, larger than the ones shown in this study. This difference in the magnitude of Pa O 2 oscillations is observed most likely because at high mean Pa O 2 levels, the oxygen-haemoglobin dissociation curve is relatively flat, meaning that small changes in the oxygen content of arterial blood (as would result from alveolar recruitment) would change the oxygen partial pressure considerably. Our study shows that these Pa O 2 oscillations are also detectable at a low mean Pa O 2 , affording a potential usefulness of the sensor in clinical settings.
In order to test the full potential of these fast sensors in diagnosing CA and in managing mechanical ventilation, further research in large animal models of ARDS is required to facilitate comparison with human adult and paediatric patients. Moreover, whether anatomical and physiological differences between species affect Pa O 2 oscillations in ARDS is unclear, so it is becoming more and more urgent to perform such studies in patients with ARDS, and in mechanically ventilated patients.
